Skip to content

Clinical trials

Phase 4 Diabetes Mellitus, Type 1 trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 1 Phase: Phase 4 Country / region: China Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20071
20101
20141
20151
20161
20172
20181
20201
20211
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Unknown status5
Active, not recruiting1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Second Xiangya Hospital of Central South University4
Shenzhen People's Hospital2
Eli Lilly and Company1
Nanjing Medical University1
Novo Nordisk A/S1
The First Affiliated Hospital with Nanjing Medical University1
Third Affiliated Hospital, Sun Yat-Sen University1
Yang Tao1
Zhejiang Provincial People's Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 113
Diabetes Mellitus, Type 23
Diabetes Mellitus2
Diabetic Nephropathies1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.